Skip to content

Clinical research for the integrated traditional and western medicine in the treatment of triple negative breast cancer

Clinical research for the integrated traditional and western medicine in the treatment of triple negative breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005547
Enrollment
Unknown
Registered
2022-01-19
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Treatment group:Sanyin prescription + Western medicine treatment

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) 18-70 years old; (2) The results of immunohistochemistry showed that Er - / < 1% + and PR - / < 1% + and HER-2 (- / +) / fish had no amplification; (3) TNM stage was ? ~ ?; (4) 3 months after pathological diagnosis to the end of chemotherapy and radiotherapy; (5) ECOG score was 0-1; (6) There was no serious organic or functional disease; (7) Willing to accept long-term TCM treatment, observation and various examinations.

Exclusion criteria

Exclusion criteria: (1) Recurrence and metastasis; (2) The patients with recurrence and metastasis are to be excluded from clinical follow-up; (3) Patients who can not take traditional Chinese medicine due to smell and other reasons; (4) Women who are lactating, pregnant or preparing for pregnancy; (5) Allergic constitution and allergic to many drugs; (6) Patients with severe primary diseases of cardio cerebrovascular, liver, kidney and hematopoietic system and mental illness; (7) Subjects who are participating in other drug trials;

Design outcomes

Primary

MeasureTime frame
DFS;

Secondary

MeasureTime frame
TCM symptom scale;OS;TpCR;QoL;

Countries

China

Contacts

Public ContactLiu Sheng
lshtcm@163.com+86 21 64385700-3722

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026